F Swan
Impact in
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 46
- Oncology 25
- Viral-associated cancers and disorders 11
- Cancer Treatment and Pharmacology 5
- Co-authors
- Fernando Cabanillas (41 shared papers)Peter McLaughlin (41 shared papers)Fredrick B. Hagemeister (30 shared papers)Maria Alma Rodriguez (31 shared papers)Jorge Romaguera (22 shared papers)William S. Velasquez (14 shared papers)J R Redman (11 shared papers)Sundar Jagannath (8 shared papers)
- Journals
- Annals of Oncology (15 papers)Journal of Clinical Oncology (13 papers)Blood (8 papers)Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
F Swan
55 papers receiving 3.1k citations
F Swan's Hit Papers
Peers
Comparison fields: 5 of 86
- Pathology and Forensic Medicine 2.5k
- Genetics 1.1k
- Oncology 1.7k
- Neurology 760
- Hematology 289
Countries citing papers authored by F Swan
This map shows the geographic impact of F Swan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Swan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Swan more than expected).
Fields of papers citing papers by F Swan
This network shows the impact of papers produced by F Swan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Swan. The network helps show where F Swan may publish in the future.
Co-authors
The 25 scholars most cited alongside F Swan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP) Hit paper breakdown → | 1988 | 487 |
| 2 | 1994 | 347 | |
| 3 | 1996 | 219 | |
| 4 | 1992 | 173 | |
| 5 | 1989 | 128 | |
| 6 | 1992 | 93 | |
| 7 | 1989 | 93 | |
| 8 | 1995 | 88 | |
| 9 | 1992 | 83 | |
| 10 | 1991 | 82 | |
| 11 | 1999 | 78 | |
| 12 | 1994 | 77 | |
| 13 | 1994 | 76 | |
| 14 | 1999 | 74 | |
| 15 | 1993 | 63 | |
| 16 | 1989 | 58 | |
| 17 | 1991 | 57 | |
| 18 | Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease. | 1988 | 57 |
| 19 | 1994 | 52 | |
| 20 | 1990 | 52 |
About F Swan
F Swan is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Pulmonary and Respiratory Medicine and Neurology, having authored 55 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (16 papers), Lung Cancer Treatments and Mutations (14 papers), CNS Lymphoma Diagnosis and Treatment (14 papers), Viral-associated cancers and disorders (11 papers), Acute Lymphoblastic Leukemia research (7 papers), Cancer Treatment and Pharmacology (5 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.5k citations), Genetics (1.1k citations), Oncology (1.7k citations), Neurology (760 citations) and Hematology (289 citations). F Swan has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Fernando Cabanillas, Peter McLaughlin, Fredrick B. Hagemeister, Maria Alma Rodriguez, Jorge Romaguera, William S. Velasquez, J R Redman, Sundar Jagannath, FB Hagemeister and JR Redman. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Blood, Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.